vTv Therapeutics
VTVT
27 hedge funds and large institutions have $1.22M invested in vTv Therapeutics in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 25 closing their positions.
1.07% less ownership
Funds ownership: 1.27% → 0.2% (-1.1%)
34% less funds holding
Funds holding: 41 → 27 (-14)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
94% less capital invested
Capital invested by funds: $20M → $1.22M (-$18.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$139K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$130K |
| 3 |
Goldman Sachs
New York
|
+$84.1K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$63.7K |
| 5 |
Jane Street
New York
|
+$45.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$3.82M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$3.4M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.85M |
| 4 |
RA
Royce & Associates
New York
|
-$1.48M |
| 5 |
JP Morgan Chase
New York
|
-$1.33M |
VTVT Hedge Fund Activity: Q2 2018 in Review
27 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2018, worth a combined $1.22M — down 94% from $20M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of VTVT and 11 opened new positions — a net loss of 14 holders — while 9 trimmed existing stakes and 5 added.
The largest buyer was Deutsche Bank, adding an estimated $139K. The largest seller was GMT Capital, exiting entirely with an estimated $3.82M sold.
- 27 institutional investors held vTv Therapeutics (VTVT) as of Q2 2018, down from 41 in Q1 2018.
- Funds reported $1.22M of vTv Therapeutics stock for Q2 2018, down 94% quarter-over-quarter.
- 11 funds opened new vTv Therapeutics positions in Q2 2018 and 25 closed out, a net change of -14 holders.
- The largest vTv Therapeutics buyer in Q2 2018 was Deutsche Bank, an estimated $139K added.
- The largest vTv Therapeutics seller in Q2 2018 was GMT Capital, an estimated $3.82M sold.
Based on aggregated 13F filings for Q2 2018.